Shuttle Pharmaceuticals
SHPH
4 hedge funds and large institutions have $306K invested in Shuttle Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
680% more capital invested
Capital invested by funds: $39.2K → $306K (+$267K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
0.03% more ownership
Funds ownership: 0% → 0.04% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$319K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$34.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $263K | +$319K | +1,224 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $28.2K | +$34.1K | +131 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $9.06K | +$11.2K | +43 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5.89K | +$3.12K | +12 | +80% |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $54 | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $20 | – | – | – |
|
|
HF
7
HRT Financial
New York
| – | -$34K | -103 | Closed |
|
SHPH Hedge Fund Activity: Q4 2024 in Review
4 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q4 2024, worth a combined $306K — up 680% from $39.2K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SHPH positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $319K. The largest seller was HRT Financial, exiting entirely with an estimated $34K sold.
- 4 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q4 2024, up from 2 in Q3 2024.
- Funds reported $306K of Shuttle Pharmaceuticals stock for Q4 2024, up 680% quarter-over-quarter.
- 3 funds opened new Shuttle Pharmaceuticals positions in Q4 2024 and 1 closed out, a net change of +2 holders.
- The largest Shuttle Pharmaceuticals buyer in Q4 2024 was Armistice Capital, an estimated $319K added.
- The largest Shuttle Pharmaceuticals seller in Q4 2024 was HRT Financial, an estimated $34K sold.
Based on aggregated 13F filings for Q4 2024.